Biotechnology for the Brain.

The blood-brain barrier blocks the development of biologic pharmaceuticals for the brain.

ArmaGen® provides platform technology solutions to the blood-brain barrier (BBB) problem and can non-invasively target recombinant proteins, therapeutic monoclonal antibodies, and siRNA to the brain.